Navigation Links
Lilly Declares Fourth-Quarter 2010 Dividend
Date:10/18/2010

INDIANAPOLIS, Oct. 18 /PRNewswire-FirstCall/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today declared a dividend for the fourth quarter of 2010 of $0.49 a share on outstanding common stock. This is the same dividend as was paid in the first three quarters of 2010 and brings the total annual dividend for 2010 to $1.96 per share.

The dividend is payable December 10, 2010 to shareholders of record at the close of business on November 15, 2010.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.  Additional information about Lilly is available at www.lilly.com.  F-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lilly Confirms Date and Conference Call for Third-Quarter 2010 Financial Results Announcement
2. Lilly CEO Says Regional Innovation Clusters Can Renew the Nations Economy
3. Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile
4. Lilly Celebrates 16th Consecutive Year as One of 100 Best Companies for Working Mothers
5. Lilly Recognized with World Business and Development Award for Tuberculosis Initiative
6. PAREXEL Announces Strategic Functional Service Provider Relationship with Eli Lilly and Company for Clinical Development in Asia/Pacific Region
7. U.S. Court of Appeals Reverses Third-Party Payor Class Certification Suit Against Lilly
8. U.S. Court of Appeals Upholds Validity of Lillys Evista Patents Through March of 2014
9. Statement from Eli Lilly and Company Regarding Approval Recommendation from FDA Advisory Committee for Expanding the Pain Indications for Cymbalta® to a Broader Pain Population
10. Lilly Halts Development of Semagacestat for Alzheimers Disease Based on Preliminary Results of Phase III Clinical Trials
11. The American Diabetes Association and Eli Lilly and Company Encourage African-Americans to Face the Music about Diabetes Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... 2017  US medical equipment and supply demand is ... Medical Equipment & Supplies: United States ... Continued increases in demand for medical services – driven ... and supported by gains in disposable personal income – ... product introductions will also drive sales as providers and ...
(Date:7/10/2017)... RESEARCH TRIANGLE PARK, N.C. , July 10, 2017 ... of a $5m Convertible Note to support the development ... led by Tencent Holdings Limited, a leading Chinese Internet ... Center. This funding will advance multiple infectious disease product ... Founded by Dr. ...
(Date:7/5/2017)... , July 5, 2017 Pace Analytical, a company of over ... today that they have acquired ESC Lab Sciences, further solidifying their position as ... United States . ... Steve Vanderboom- President and CEO of Pace Analytical ... ESC Lab Sciences out of Mt Juliet, TN , enhances ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... , ... “Kids aren't born knowing how to regulate their emotions any more ... of St. Louis-based positive education company Generation Mindful. To help with that daunting task, ... , The kit uses colorful, engaging and educational illustrations and games to teach ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... Houston, Texas (PRWEB) , ... July 20, 2017 ... ... and litigation law firm headquartered in Houston, is pleased to announce their expansion ... decades of affordable housing experience, directors Alysse Hollis and Ronald Bell, and of ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, ... devices and systems for monitoring cardiopulmonary diseases, announced today that it has raised ... complete regulatory submissions and fund final engineering and initial production of the Company’s ...
(Date:7/20/2017)... ... , ... There’s a lot of confusing lingo out there surrounding spinal disc ... But it’s crucial to understand both the differences and similarities between these two highly ... PhD, founder and president of Atlantic Spine Center . , The bottom ...
Breaking Medicine News(10 mins):